STAT1 and prostate cancer: Onnis et al43 showed that IL-11 activates an oncogenic signalling pathway, through STAT1 and 3, that increased anchorage-independent growth in prostate cancer PC3, colon cancer HCT116, and renal cancer RCC4 cells.